The comparison of efficacy and safety between continuation and discontinuation of methotrexate(MTX)at the commencement of etanercept in patients with active rheumatoid arthritis despite MTX therapy : 24-week results from the JESMR study.
The comparison of efficacy and safety between continuation and discontinuation of methotrexate(MTX)at the commencement of etanercept in patients with active rheumatoid arthritis despite MTX therapy : 24-week results from the JESMR study.
复制标题
尽管接受了 MTX 治疗，但活动性类风湿性关节炎患者在开始依那西普治疗时继续和停止甲氨蝶呤 (MTX) 的疗效和安全性比较：JESMR 研究的 24 周结果。
DOI：
--
复制
发表时间：
2010
期刊：
影响因子：
--
通讯作者：
Japan Biological Agent Integrated Consortium(J-BASIC).
中科院分区：
文献类型：
--
作者：
Kameda H;Ueki Y;Saito K;Nagaoka S;Hidaka T;Atsumi T;Tsukano M;Kasama T;Shiozawa S;Tanaka Y;Takeuchi T;Japan Biological Agent Integrated Consortium(J-BASIC).
